The largest epidemiological study to date on multidrug-resistant Klebsiella pneumoniae in Saudi hospitals highlights the need ...

NDAQ:ACXP) Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules ...

Hospitals in New Jersey rank fifth best in the nation for protecting patients from injuries and medical errors and preventing ...

Pune: Doctors have reported a steady increase in infections resistant to antibiotics among children in the city, indicating that humans without the us.

The guidelines recommend a 4-month drug regimen for adults and children with drug-susceptible TB, and a 6-month regimen for ...

Researchers also find that patients with penicillin allergy labels were more likely to get broad-spectrum antibiotics and ...

Most diabetic wound care products are passive dressings, only providing a protective barrier against the external environment ...

HY-133 is under clinical development by HyPharm and currently in Phase I for Staphylococcal Infections. According to GlobalData, Phase I drugs for Staphylococcal Infections have a 63% phase transition ...

P-128 is under clinical development by GangaGen Biotechnologies and currently in Phase II for Staphylococcus aureus Infections.

MRSA - or methicillin resistant staphylococcus ... This indicates that new strains are spreading which are resistant to traditional treatment. He added: 'If the new community-acquired MRSA clones ...

According to the GoFundMe page, Ed Rivas contracted a bacteria known as MRSA, or Methicillin-resistant Staphylococcus aureus. It is a type of staph bacteria that causes difficult-to-treat infections.